Онкология
2394 статей · 70 журналов
Журналы подкатегории (70)
- Blood Neoplasia · Elsevier (100)
- Cancer Treatment and Research Communications · Elsevier (98)
- Brachytherapy · Elsevier (96)
- European Journal of Surgical Oncology · Elsevier (96)
- Cancer Epidemiology · Elsevier (95)
- The Lancet Oncology · Elsevier (95)
- International Journal of Gynecological Cancer · Elsevier (93)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- EJC Skin Cancer · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (84)
- Lung Cancer · Elsevier (77)
- Asia-Pacific Journal of Clinical Oncology · Wiley (76)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (73)
- Critical Reviews in Oncology/Hematology · Elsevier (70)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Cancer Letters · Elsevier (57)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (25)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Exploring the evolving landscape of bispecific FVIIIa-mimetic antibodies in haemophilia A
- Integrating functional marrow reserve and molecular risk improves prediction of post-transplant outcomes in HMA-treated myelodysplastic syndromes
- Rosai-Dorfman disease: a 30-year institutional study of clinical features, treatment patterns, and outcomes
- Low lymphoma macrophage infiltration predicts poor outcomes for R-CHOP– but not Pola-R-CHP–treated patients with DLBCL
- CDK4/6i reverses MEIS2 inhibition of CRL4CRBN and promotes BCMA loss to enhance IMiD/CELMoD therapy in multiple myeloma
- Palbociclib in combination with dexamethasone, bortezomib, and doxorubicin for pediatric relapsed acute lymphoblastic leukemia
- CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study
- Abnormal serum immunofixation patterns are common after BCMA CAR-T in multiple myeloma and are preceded by immune events
- Fixed-treatment duration venetoclax following covalent BTKi progression in chronic lymphocytic leukemia
- Soluble B-cell maturation antigen as a biomarker of progression and treatment response in patients with myeloma precursors
- Immunologic changes during treatment with romidepsin, azacitidine, and lenalidomide in relapse/refractory T-cell lymphoma
- IMiD-based monotherapy for maintenance of remission in primary CNS lymphoma: a single-center experience
- Kinetic BCR::ABL1 reduction by transcript types in frontline CML treatment: a GIMEMA LabNet CML network survey
- Combination therapy with nelarabine, pegaspargase, and venetoclax for adult patients with R/R T-cell ALL/LBL
- GATA-3 identifies a distinct subset of T-PLL associated with skin involvement and CCR4 expression
- MCL1 inhibition exerts potent antileukemic activity by restoring apoptosis in T-lineage acute lymphoblastic leukemia
- Venetoclax plus hypomethylating agent improves response rates but not survival in TP53-mutated myelodysplastic syndromes
- Adkins J, Zhao C. Lineage switch in leukemia and lymphoma: case reports and molecular and cellular mechanisms. Blood Neoplasia. 2026;3(4):100265.
- PLK4 inhibition by CFI-400945 triggers polyploidy and synergistic apoptosis with venetoclax in TP53-mutant AML
- Circulating Multiple Myeloma Cell Kinetics and Genomic Profiling Predict Resistance to Targeted Immunotherapies
- Dual EZH2 & Histone Deacetylase Inhibition Suppresses Cell Viability in Down Syndrome Myeloid Leukemia by Depleting EZH2
- Immunity and inflammation in classic Hodgkin lymphoma: Bridging diagnosis, prognosis and precision medicine
- Actimab-A, a CD33-targeted Actinium-225 radioconjugate, drives potent mutation-agnostic efficacy in AML models
- Environmental risk factors for acute myeloid leukemia in adults, a systematic review
- From smoke to stemness: Mechanisms of cancer stem cell induction by cigarette smoke
- Endothelial dysfunction in cancer: A neglected frontier in anticancer therapy
- Metabolic and epigenetic plasticity of tumor-associated macrophages shapes immunosuppressive outputs and immune checkpoint response
- Tertiary lymphoid structures in pancreatic cancer: molecular mechanisms, heterogeneity, and clinical significance
- Metabolic regulation of tumor angiogenesis in colorectal cancer: mechanisms and therapeutic opportunities
- Antibody–drug conjugates in treatment-resistant hepatocellular carcinoma: mechanistic insights, translational barriers, and a blueprint for salvage-line precision oncology